Sort
141,003 grants matching “cytokine”
Brain-Imaging Markers of Neurotoxicity and Long-Term Outcomes after CAR-T Cell Therapy
$676,469Ravi Bansal · Children'S Hospital Of Los Angeles · R01 · FY2024 · CA
Cardiopulmonary Risk Assessment from Smoke Exposure at the Wildland Urban Interface
$676,467Jessica M Oakes · Northeastern University · R01 · FY2025 · ES
A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
$676,427Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2014 · AA
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease
$676,397Andria Lee Ford · Washington University · R01 · FY2021 · HL
Leadership, Planning, and Evaluation
$676,378Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA
Genetically-engineered stem cells for self-regulating arthritis therapy
$676,370Farshid Guilak · Washington University · R01 · FY2022 · AR
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settings
$676,352Kevin B Urdahl · Seattle Children'S Hospital · R01 · FY2020 · AI
AUTOIMMUNITY: TREATMENT BY COSTIMULATORY SIGNAL BLOCKADE
$676,340Brigham And Women'S Hospital · U19 · FY2001 · AI
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$676,329Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2020 · CA
Genetic modifiers of APOE-related risk for AD
$676,279Alison M Goate · Mayo Clinic Jacksonville · U19 · FY2025 · AG
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$676,263John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$676,263John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
An observational study of the effects of edible cannabis and its constituent cannabinoids on pain, inflammation, and cognition
$676,228L. Cinnamon Bidwell · University Of Colorado · R01 · FY2020 · AT
Neurosarcoidosis: Clinical Phenotype, Biomarkers and Immunopathogensis
$676,226Carlos A Pardo-Villamizar · Johns Hopkins University · R01 · FY2022 · NS
Role of estradiol and related hormones on inflammation, sleep, and risks for Alzheimer's disease
$676,171Whitney Lee Wharton · Emory University · R01 · FY2023 · AG
Development of a topical malaria vaccine.
$676,165Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2016 · AI
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
$676,113Theresa A Freeman · Thomas Jefferson University · R01 · FY2022 · AR
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$676,067Devendra K. Agrawal · Creighton University · R01 · FY2013 · HL
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis
$676,059Braham Shroot · Signum Biosciences · R44 · FY2014 · AR
Dietary Effects on Imaging and Fluid-based Biomarkers of the Adipose-Brain Axis in Alzheimers Disease
$676,042Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2019 · AG
Dietary Effects on Imaging and Fluid-based Biomarkers of the Adipose-Brain Axis in Alzheimers Disease
$676,042Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2020 · AG
Early identification of immunotherapy resistance through integrated multiparameter imaging
$676,006Mekhail Anwar · University Of California, San Francisco · R01 · FY2025 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$675,999Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$675,999Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition
$675,996Thomas Hope · Northwestern University At Chicago · R01 · FY2020 · AI